Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0000950170-24-009005

SVP, CFO acquired 792 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Taylor Daphne SVP, CFO 2024-01-29 Option exercise +792 13,160 D
Derivatives
Taylor Daphne SVP, CFO 2024-01-29 Option exercise · Restricted Stock Unit −792 0 D
Loading xslF345X05/ownership.xml…